Notes to the Consolidated Financial Statements continued 15.
Deferred Taxes a Recognised Deferred Tax Assets and Liabilities Deferred tax assets and liabilities are attributable to the following: Assets Liabilities Net 2018 2017 2018 2017 2018 2017 m m m m m m Intangible assets 98.4 61.3 98.4 61.3 Property, plant and equipment 3.4 3.8 3.4 3.8 Inventories 0.9 0.8 0.9 0.8 Receivables payables 1.2 3.5 1.2 3.5 Share-based payments 2.4 1.6 2.4 1.6 Losses 2.1 8.4 2.1 8.4 R&D tax credits 1.2 1.3 1.2 1.3 Employee benefit obligations 1.0 1.0 1.0 1.0 8.8 16.6 101.8 65.1 93.0 48.5 Deferred tax assets and liabilities are offset to the extent that there is a legally enforceable right to offset current tax assets against current tax liabilities.
b Unrecognised Deferred Tax The aggregate amount of gross temporary differences associated with investments in subsidiaries for which deferred tax liabilities have not been recognised is 1.8 million 2017: 1.5 million.
The estimated unprovided deferred tax liability in relation to these temporary differences is 0.1 million 2017: 0.1 million.
Deferred tax assets in relation to losses amounting to 0.9 million 2017: 1.1 million have not been recognised due to uncertainty over their recoverability.
Included within unrecognised losses are 0.7 million of losses which expire prior to 2030.
Other losses may be carried forward indefinitely.
c Movements during the Year Acquired Balance at through Foreign Balance at 1 July Recognised business Recognised exchange 30 June 2016 in income combinations in equity OCI adjustments 2017 m m m m m m Intangible assets 63.7 11.1 6.4 2.3 61.3 Property, plant and equipment 3.8 0.1 0.1 3.8 Inventories 0.1 1.3 0.3 0.1 0.8 Receivables payables 1.6 1.9 3.5 Share-based payments 1.4 0.1 0.1 1.6 Losses 14.0 6.2 0.6 8.4 R&D tax credits 0.9 0.5 0.1 1.3 Employee benefit obligations 1.2 0.3 0.5 1.0 48.5 8.9 6.7 0.4 1.8 48.5 Acquired Balance at through Foreign Balance at 1 July Recognised business Recognised exchange 30 June 2017 in income combinations in equity OCI adjustments 2018 m m m m m m Intangible assets 61.3 26.6 64.6 0.9 98.4 Property, plant and equipment 3.8 0.4 3.4 Inventories 0.8 2.0 2.0 0.1 0.9 Receivables payables 3.5 2.3 1.2 Share-based payments 1.6 0.1 0.9 2.4 Losses 8.4 6.1 0.2 2.1 R&D tax credits 1.3 0.1 0.2 1.2 Employee benefit obligations 1.0 1.0 48.5 20.6 66.6 0.9 0.6 93.0 136 Dechra Pharmaceuticals PLC Annual Report and Accounts for the year ended 30 June 2018 www.
